Learn more about Zepbound Weight Loss in Florida Mounjaro is a tirzepatide-based medication commonly associated with type 2 diabetes care
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al
We understand that starting a new medication can be daunting, and our team is dedicated to providing guidance and support to manage any potential side effects, such as nausea or gastrointestinal discomfort, ensuring a smooth transition for our patients
Single-use pens (such as Wegovy, Trulicity, and Mounjaro) have different storage requirements than multi-dose pens, so follow the specific guidance for your product
Blood levels of CRP above 3 mg/L are suggested to be predictive of adverse cardiovascular outcome one year later 48
Originally approved by the FDA for the treatment of adult obesity in 2014, the drug received authorisation in 2020 for obesity in adolescents aged 12-17 years old (Mller, Blher, Tschp, DiMarchi)